Chairman of the Polpharma Group Supervisory Board Jerzy Starak talks about the company’s roadmap in Kazakhstan and future exports to the EU. With 12 years of comprehensive investments in the…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…